Actively Recruiting
Safely Reduce Cystoscopic Evaluations for Hematuria Patients
Led by Erasmus Medical Center · Updated on 2023-09-06
1100
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The SeARCH-trial assess the clinical impact of a molecular urine test as a 'urine-first' strategy in the diagnostic workup of patients presenting with microscopic hematuria.
CONDITIONS
Official Title
Safely Reduce Cystoscopic Evaluations for Hematuria Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Microscopically confirmed microscopic hematuria of voided urine defined as 63 erythrocytes per high power field
- Male patients 640 years
- Female patients 650 years
You will not qualify if you...
- History of urothelial bladder or urinary tract cancer
- Presence of macroscopic (visible) hematuria
- Woman who is or may be pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
SeARCH-trial Pijpers
Rotterdam, Netherlands, 3015GD
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here